2-[2-(4-(trifluoromethyl)phenylamino)thiazol-4-yl]acetic acid (Activator-3) is a potent activator of AMPK
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
2-[2-(4-(trifluoromethyl)phenylamino)thiazol-4-yl]acetic acid (Activator-3) is a potent activator of AMPK
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-06-19
DOI
10.1038/s41598-018-27974-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy
- (2017) Robert W. Myers et al. SCIENCE
- Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy
- (2016) Kimberly O. Cameron et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural basis of allosteric and synergistic activation of AMPK by furan-2-phosphonic derivative C2 binding
- (2016) Christopher G. Langendorf et al. Nature Communications
- Investigation of Chitosan for Prevention of Diabetic Progression Through Gut Microbiota Alteration in Sugar Rich Diet Induced Diabetic Rats
- (2015) Bhumika Prajapati et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Co-activator binding protein PIMT mediates TNF-α induced insulin resistance in skeletal muscle via the transcriptional down-regulation of MEF2A and GLUT4
- (2015) Vasundhara Kain et al. Scientific Reports
- Choreography of AMPK activation
- (2014) Christopher G Langendorf et al. CELL RESEARCH
- Mechanism of Action of Compound-13: An α1-Selective Small Molecule Activator of AMPK
- (2014) Roger W. Hunter et al. CHEMISTRY & BIOLOGY
- Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus
- (2014) A. Michael Lincoff et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- g_mmpbsa—A GROMACS Tool for High-Throughput MM-PBSA Calculations
- (2014) Rashmi Kumari et al. Journal of Chemical Information and Modeling
- UniProt: a hub for protein information
- (2014) NUCLEIC ACIDS RESEARCH
- Pharmacokinetics
- (2013) Jianghong Fan et al. BIOCHEMICAL PHARMACOLOGY
- AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net Phosphorylation
- (2013) Graeme J. Gowans et al. Cell Metabolism
- The Med1 Subunit of the Mediator Complex Induces Liver Cell Proliferation and Is Phosphorylated by AMP Kinase
- (2013) Navin Viswakarma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Conserved regulatory elements in AMPK
- (2013) Lei Chen et al. NATURE
- ERK2-Mediated Phosphorylation of Transcriptional Coactivator Binding Protein PIMT/NCoA6IP at Ser298 Augments Hepatic Gluconeogenesis
- (2013) Bandish Kapadia et al. PLoS One
- Physiological and Toxic Effects of Purine Intermediate 5-Amino-4-imidazolecarboxamide Ribonucleotide (AICAR) in Yeast
- (2011) Hans C. Hürlimann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure of mammalian AMPK and its regulation by ADP
- (2011) Bing Xiao et al. NATURE
- AMP-activated protein kinase: nature's energy sensor
- (2011) David Carling et al. Nature Chemical Biology
- Therapeutic Potential of Aleglitazar, a New Dual PPAR-α/γ Agonist
- (2010) Matthew A. Cavender et al. American Journal of Cardiovascular Drugs
- I-TASSER: a unified platform for automated protein structure and function prediction
- (2010) Ambrish Roy et al. Nature Protocols
- A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis
- (2010) Jorge E. Gómez-Galeno et al. ACS Medicinal Chemistry Letters
- Targeting the AMPK pathway for the treatment of Type 2 diabetes
- (2009) Benoit Viollet Frontiers in Bioscience-Landmark
- Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study
- (2009) Robert R Henry et al. LANCET
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
- (2009) Carles Cantó et al. NATURE
- Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients
- (2008) H. Boon et al. DIABETOLOGIA
- GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation
- (2008) Berk Hess et al. Journal of Chemical Theory and Computation
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started